Skip to content
Sign in

JNJ · NYSE

Johnson & Johnson (JNJ) Stock Price & Fundamentals

$897.05+0.44%+$3.94End-of-day price as of Oct 9, 2026

Johnson & Johnson (JNJ) closed at $897.05 on Oct 9, 2026, up 0.44% from the previous close of $893.11.

Share price, past year

1Y +9.71%

52-week range $753.21 – $897.36. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$897.05
Sep 30, 2026$867.06
Aug 31, 2026$843.83
Jul 31, 2026$841.42
Jun 30, 2026$794.73
May 29, 2026$839.97
Apr 30, 2026$847.73
Mar 31, 2026$797.38
Feb 27, 2026$827.18
Jan 30, 2026$799.70
Dec 31, 2025$784.75
Nov 28, 2025$761.51
Oct 31, 2025$801.91

Key statistics

Market cap
$2.16T
P/E (TTM)
104.2
EPS (TTM)
$8.61
Revenue (TTM)
$97.93B
Net income (TTM)
$21.04B
Shares outstanding
2.4B
Dividend yield
—
52-week range
$753.21 – $897.36

Johnson & Johnson's market cap is $2.16T, based on a share price of $897.05 and 2.4B shares outstanding as of Jul 17, 2026.

Financials

Johnson & Johnson reported revenue of $94.19B for fiscal 2025, up 6.05% from fiscal 2024.

Johnson & Johnson earned net income of $26.80B in fiscal 2025, a net margin of 28.5%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY21FY22FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Johnson & Johnson annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 28, 2025$94.19B+6.1%$26.80B28.5%$11.03$19.70B
FY2024ended Dec 29, 2024$88.82B+4.3%$14.07B15.8%$5.79$19.84B
FY2023ended Dec 31, 2023$85.16B+6.5%$35.15B41.3%$13.72$18.25B
FY2022ended Jan 1, 2023$79.99B+1.6%$17.94B22.4%$6.73$17.19B
FY2022ended Jan 2, 2022$78.74B−4.7%$17.94B22.8%$6.73$17.19B
FY2021ended Jan 3, 2021$82.58B+0.6%$14.71B17.8%$5.51$20.19B
FY2019ended Dec 29, 2019$82.06B+0.6%$15.12B18.4%$5.63$19.92B
FY2018ended Dec 30, 2018$81.58B+6.7%$15.30B18.8%$5.61$18.53B
FY2017ended Dec 31, 2017$76.45B+6.3%$1.30B1.7%$0.47$17.78B
FY2016ended Jan 1, 2017$71.89B—$16.54B23.0%$5.93$15.54B
Johnson & Johnson quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 28, 2026$25.31B$5.53B$2.27
Q1 FY2026ended Mar 29, 2026$24.06B$5.24B$2.14
Q4 FY2025ended Dec 28, 2025$24.56B$5.12B$2.08
Q3 FY2025ended Sep 28, 2025$23.99B$5.15B$2.12
Q2 FY2025ended Jun 29, 2025$23.74B$5.54B$2.29
Q1 FY2025ended Mar 30, 2025$21.89B$11.00B$4.54
Q4 FY2024ended Dec 29, 2024$22.52B$3.43B$1.41
Q3 FY2024ended Sep 29, 2024$22.47B$2.69B$1.11

Company profile

Name
Johnson & Johnson
Ticker
JNJ
Exchange
NYSE
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
One Johnson & Johnson Plz, New Brunswick, NJ 08933
Incorporated in
NJ
Fiscal year ends
January
SEC CIK
0000200406

Recent SEC filings

Frequently asked questions

What is Johnson & Johnson's stock price?

Johnson & Johnson (JNJ) closed at $897.05 on Oct 9, 2026, up 0.44% from the previous close of $893.11.

What is Johnson & Johnson's market cap?

Johnson & Johnson's market cap is $2.16T, based on a share price of $897.05 and 2.4B shares outstanding as of Jul 17, 2026.

How much revenue does Johnson & Johnson make?

Johnson & Johnson reported revenue of $94.19B for fiscal 2025, up 6.05% from fiscal 2024.

What is JNJ's P/E ratio?

Johnson & Johnson's price-to-earnings ratio is 104.2, based on trailing twelve-month diluted EPS of $8.61.

Does Johnson & Johnson pay a dividend?

Johnson & Johnson's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Johnson & Johnson's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures